Organization: Eastern Technology Seed Investment Fund

Diabetogen completes first round financing

Diabetogen Biosciences Inc, London ON, has raised $7.8 million in first-round equity investment to move its technology platform for the treatment of autoimmune diseases towards clinical trials. The firm is currently working towards treatment for Type I diabetes. The financing was provided by the Business Development Bank of Canada Venture Capital Division, VentureLink Group of…

ATMOS nets $10 million for DRAM product development

ATMOS Corp, Kanata ON, has completed a US$10-million round of financing to accelerate development and marketing of its embedded memory solutions for system-on-a-chip (SoC) applications. The firm’s plans for dynamic random access memory (DRAM) products and design automation tools attracted investment of $5 million from Virage Logic Corp, Fremont CA. The remainder was provided by…